Company Profile
Xvivo Perfusion AB (publ), a medical technology company develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden.
Its business is organized into Thoracic. Its portfolio also includes Abdominal, Services, and segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours.
Its portfolio also includes Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination, XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process, and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient, as well as Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution.
Its portfolio also includes XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS, XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs, and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment.
Additionally, it offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion Gisto, an integrated system for organ transportation.
It operates in Sweden. Its portfolio also includes The Netherlands, The United States, Italy, North and South America, Asia/Pacific and Oceania, and globally. Incorporated in 1998, Xvivo Perfusion AB (publ) is headquartered in Mölndal, Sweden.